Yuki Imaoka, Masahiro Ohira, Yuka Tanaka, Toshihiro Nakayama, Miho Akabane, Shinichiro Yokota et al. Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients. // Journal of Hepato-Biliary-Pancreatic Sciences. – 2026. – DOI: 10.1002/jhbp.70178. – URL: https://onlinelibrary.wiley.com/doi/10.1002/jhbp.70178?af=R
Yuki Imaoka, Masahiro Ohira, Yuka Tanaka, Toshihiro Nakayama, Miho Akabane, Shinichiro Yokota, Sheri M. Krams, Olivia M. Martinez, Carlos O. Esquivel, Kazunari Sasaki, & Hideki Ohdan (2026). Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70178
Yuki Imaoka, et al. “Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients.” Journal of Hepato-Biliary-Pancreatic Sciences, 2026. doi:10.1002/jhbp.70178.
@article{Imaoka2026,
title = {Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients},
author = {Imaoka, Yuki and Ohira, Masahiro and Tanaka, Yuka and Nakayama, Toshihiro and Akabane, Miho and Yokota, Shinichiro and Krams, Sheri M. and Martinez, Olivia M. and Esquivel, Carlos O. and Sasaki, Kazunari and Ohdan, Hideki},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
doi = {10.1002/jhbp.70178},
url = {https://onlinelibrary.wiley.com/doi/10.1002/jhbp.70178?af=R}
}